Loading...
•
Mar 31, 2021
ICU Medical Q1 2021 Earnings Report
ICU Medical's first quarter results were generally in line with expectations, with revenue at $318.0 million and adjusted diluted earnings per share at $1.62.
Key Takeaways
ICU Medical reported first quarter 2021 results with revenue of $318.0 million, a decrease compared to $328.6 million in the same period last year. GAAP net income was $23.7 million, or $1.09 per diluted share, compared to $16.8 million, or $0.78 per diluted share, for the first quarter of 2020. Adjusted diluted earnings per share were $1.62, as compared to $1.81 for the first quarter of 2020.
First quarter revenue was $318.0 million, compared to $328.6 million in the same period last year.
GAAP gross profit was $112.7 million, compared to $121.4 million in the same period last year.
GAAP net income was $23.7 million, or $1.09 per diluted share, compared to $16.8 million, or $0.78 per diluted share, for the first quarter of 2020.
Adjusted diluted earnings per share were $1.62 as compared to $1.81 for the first quarter of 2020.
ICU Medical
ICU Medical
ICU Medical Revenue by Segment
Revenue by Segment
Consumables Revenue
CapyFin.comInfusion Systems Revenue
CapyFin.com Forward Guidance
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.
Revenue & Expenses
Visualization of income flow from segment revenue to net income